Original Source(s)
Related Content
Photodynamic therapy gains FDA approval for superficial BCC
Phase 3 trial data showed greater clinical and histological clearance than with placebo photodynamic therapy.
September 15, 2026
-
2 min
FDA approves FET-PET agent for glioma
The radioactive diagnostic drug is indicated in patients aged 1 month or older and is used in conjunction with other diagnostic evaluations.
September 14, 2026
-
2 min
Retained silk may underlie late postvasectomy fistula
Surgery and histopathology identified retained silk ligature with chronic inflammation at the site of a rare fistula presenting 3 years following vasectomy.
September 18, 2026
-
4 min
